share

ACC Reaffirms Support for Endocrine Screening Program and Offers Recommendations to Improve Implementation


Contact: Scott Jensen (202) 249-6511  
Email: scott_jensen@americanchemistry.com

WASHINGTON (June 14, 2013) – The Environmental Protection Agency (EPA) recently released certain procedures and documents related to their Endocrine Disruptor Screening Program (EDSP). The American Chemistry Council (ACC) issued the following statement in response:

“The American Chemistry Council (ACC) supports the U.S. Environmental Protection Agency’s (EPA) Endocrine Disruptor Screening Program (EDSP) and continues to play a constructive role in the development of the program. Our goal is to see the EDSP implemented as efficiently as possible and in a manner consistent with the law, science and our members’ commitment to the safe use of chemicals.

“We will review the EDSP procedures and documents the Agency has just released and comment, as warranted. It is important for EPA to emphasize, as it has done in the FR notice, that substances on List 2 are not endocrine disruptors. They have simply been selected by the Agency for EDSP screening based only on their pesticide registration status and/or because such substances may occur in sources of drinking water.

“For many years, ACC has been urging the agency to develop the tools needed to implement the program so that it ensures public safety and establishes a workable program for the marketplace. More recently, we provided comments to the agency outlining many recommendations on how the agency can make this a robust, science-based and procedurally sound program as it looks to complete screening of the EDSP List 1 substances before moving on to List 2.

“We have always encouraged the Agency to fully evaluate the performance of current EDSP testing and make adjustments based on lessons learned before moving on to testing a new list of chemicals. Any of the Tier 1 assays which do not perform adequately should be revised or replaced with other validated approaches before EPA begins screening List 2 substances. In addition, the Agency should consider accelerating the evaluation and validation of relevant high-throughput assays as potential replacements for some current Tier 1 assays. These recommended actions would improve the scientific basis of the EDSP and minimize the need for additional animal testing.

“We look forward to working constructively with the Agency and other stakeholders to ensure this program is implemented in a scientifically sound and timely manner and is to everyone's benefit—the public, EPA, industry, NGOs and animal welfare organizations.”

» Learn more about endocrine disruption

From: 
Email:  
To: 
Email:  
Subject: 
Message: